Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
10.14
+0.25 (2.53%)
At close: Mar 9, 2026, 4:00 PM EDT
9.80
-0.34 (-3.33%)
After-hours: Mar 9, 2026, 7:44 PM EDT

Relay Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Market Capitalization
1,8121,4666901,3571,8063,318
Upgrade
Market Cap Growth
164.72%112.63%-49.19%-24.86%-45.56%-11.11%
Upgrade
Enterprise Value
1,290903-1006018132,725
Upgrade
Last Close Price
10.148.464.1211.0114.9430.71
Upgrade
PS Ratio
118.0395.4968.9153.131307.871095.42
Upgrade
PB Ratio
3.112.590.891.811.903.70
Upgrade
P/TBV Ratio
3.202.590.891.811.913.71
Upgrade
EV/Sales Ratio
84.0358.82-23.53588.46899.58
Upgrade
Debt / Equity Ratio
0.060.060.060.070.060.03
Upgrade
Net Debt / Equity Ratio
-0.92-0.92-0.94-0.93-0.99-1.04
Upgrade
Net Debt / EBITDA Ratio
1.751.751.931.863.074.21
Upgrade
Net Debt / FCF Ratio
2.212.212.922.293.9512.01
Upgrade
Asset Turnover
0.020.020.010.030.000.00
Upgrade
Quick Ratio
21.6821.6815.4024.7815.7639.60
Upgrade
Current Ratio
22.6122.6115.9525.4416.0040.14
Upgrade
Return on Equity (ROE)
-41.12%-41.12%-44.15%-40.18%-31.44%-43.81%
Upgrade
Return on Assets (ROA)
-25.35%-25.35%-28.11%-24.40%-18.44%-15.63%
Upgrade
Return on Capital Employed (ROCE)
-50.80%-50.80%-47.00%-46.60%-30.00%-23.00%
Upgrade
Earnings Yield
-15.26%-18.86%-48.97%-25.20%-16.08%-10.97%
Upgrade
FCF Yield
-13.01%-16.09%-36.41%-22.43%-13.21%-2.35%
Upgrade
Buyback Yield / Dilution
-20.10%-20.10%-16.55%-9.21%-17.97%-123.22%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.